PTHS - Chromocell Therapeutics Corp
23.12
0.710 3.071%
Share volume: 2,622
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$22.41
0.71
0.03%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 03-27-2025 | 05-13-2025 | 11-13-2025 | |
| Total revenue | -3.527 K | 0.000 | 7.406 M | |
| Cost of revenue | 0.000 | 0.000 | 2.316 M | |
| Gross profit | -3.527 K | 0.000 | 5.090 M | |
| 100.00% | inf% | |||
| Operating expenses | 1.825 M | 1.834 M | 19.773 M | |
| Selling general and admin | 1.540 M | 1.640 M | 19.628 M | |
| Research and development | 285.236 K | 194.298 K | 145.000 K | |
| Total expenses | 1.825 M | 1.834 M | 20.452 M | |
| 0.49% | 1,015.17% | |||
| Operating income | -1.825 M | -1.834 M | -15.362 M | |
| Ebit | -1.825 M | -1.834 M | -15.357 M | |
| Pretax income | -1.927 M | -1.968 M | -16.703 M | |
| 2.12% | 748.90% | |||
| Income tax | 0.000 | 0.000 | -465.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -1.927 M | -1.968 M | -16.238 M | |
| -2.12% | -725.26% |